top biopharmaceuticals for glp-1 medication Major global pharma updates in July 2026 feature massive market movements in the obesity and segments, multi-billion dollar M&A deals, and new clinical milestones in regenerative and Prescription GLP-1s for Weight Loss

The emergence of GLP-1R as a popular target for weight loss is mainly attributed to its mechanistic features and the weight reduction efficacy shown by liraglutide and semaglutide

Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors

From 2018 to 2021, Biktarvy's sales were $1.18 billion, $4.74 billion, $7.26 billion, and $8.62 billion, respectively

This process helps quiet food noise, constant, intrusive thoughts about your next meal that can make weight management difficult

Long-acting injectables may become initial treatments, followed by oral maintenance therapies